IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome

Exclusion Criteria

• •Elective surgical procedure planned within 12 months
• •Life expectancy ≤1 year
• •Known allergy or intolerance to aspirin, ticagrelor or nonsteroidal anti-inflammatory drugs (NSAIDs)
• •History of cerebral hemorrhage
• •History of stroke in six months
• •Active bleeding
• •Known relevant hematological deviations
• •Known, clinically important thrombocytopenia (i.e., \<100\*10\^9/L) or anemia (i.e., \<90g/L)
• •Active cancer
• •Concomitant use of oral anticoagulants
• •Active participation in another clinical study
• •Other situations in which the investigator considers unsuitable to attend the study